Companies featured in this edition of the newsletter: ACTC, CUR, CVM, DKAM, ENZ, IMUC, MFGD, NXOI, OMCM, ONEZ, PSID, XSNX

Markets continued to carry momentum during the early stages of last week, as the absence of significant economic news led to a continuation of the upward trend characterizing the past few weeks, until an earnings miss from Dell on Thursday led to a selloff in the technology sector which caused the major indices to end the week mixed. All told, the Dow ended the week in positive territory, gaining 47 points to close at 10318, up 0.5% on the week and 17.6% on the year. The Nasdaq surrendered 1.0% to close at 2146, paring its YTD gains to 36.1%, while the S&P 500 and Russell 2000 lost 0.2% and 0.3% respectively, reducing their yearly gains to 20.8 and 17.1.

Things got off to a strong start on Monday, with the

DrStockPick.com Stock Report!

Friday August 14, 2009

**************************************************************

Otelco Inc. (NASDAQ: OTT), a wireline telecommunication services provider in Alabama, Maine, Massachusetts, Missouri and West Virginia, today announced that its Board of Directors has declared a distribution of $0.42 per Income Deposit Security (each an “IDS”), which will be made on September 30, 2009 to holders of record at the close of business on September 15, 2009. The distribution represents the nineteenth consecutive quarterly distribution since the company completed its initial public offering in December 2004.

Arden Group, Inc. (Nasdaq:ARDNA) announced that its Board of Directors has declared a regular quarterly dividend of 25 cents per share of Class A

RXi Pharmaceuticals Corporation (NASDAQ: RXII) reported today that it has hired Dr. Anastasia Khvorova to fill the new post of Chief Scientific Officer (CSO). RXi Pharmaceuticals expects to benefit from the six years of experience Khvorova gained in the development and supply of RNAi compounds in her last job as CSO of Dharmacon, Inc.

According to company President and CEO, Dr. Tod Woolf, Khvorova’s appointment adds to the scope and depth of RXi’s talent in the RNAi field. “Among her many accomplishments,” noted Woolf, “Dr. Khvorova’s group at Dharmacon designed and manufactured RNAi compounds targeting virtually all of the known human genes. Moreover, Dr. Khvorova is one of the most widely cited authors of research articles in the field of RNAi, which serves as a testament to the impact her work has had in the field. Through her ground-breaking research, Dr. Khvorova also developed “self-delivering” RNAi compounds

Founded in 1988, ThermoEnergy Corporation is an integrated technologies company that trades on the OTCBB. As part of the Waste Management industry they strive to think ‘clean and green’ when it comes to their business. They engage in the worldwide commercialization of patented and/or proprietary municipal and industrial wastewater treatment. In addition, they involve themselves in clean energy technologies.

ThermoEnergy has their headquarters in Little Rock, Arkansas, as well as offices in Worcester and Hudson, Massachusetts, and New York, New York. The company serves municipal, industrial, and agricultural markets in the United States. Their wastewater treatment technologies provide cost savings for their customers in demanding applications. Their clean combustion technology helps their customers who rely on oil or natural gas to switch to cheaper energy sources while meeting air emission standards and providing for full CO2 capture.

ThermoEnergy Corporation’s technologies provide solutions for removing nitrogen from wastewater streams. Their ThermoFuel process is

Over year ago my sons and I were waiting at the train station in Worcester, MA for a family member to come for a visit. My kids, who were three and thought Thomas The Tank Engine was (and still is) the coolest thing in the world wanted to leave early that day so they could watch the freight trains in the rail yard.